Ocular Toxoplasmosis: Advances in Toxoplasma gondii Biology, Clinical Manifestations, Diagnostics, and Therapy
Pathogens · 14.10.2024 · 13 (10) · 898
DOI: 10.3390/pathogens13100898 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathogens, online erschienen am 14.10.2024. Verfasst von Miki Miyagaki und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology & Visual Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo 113-8510, Ja…. Hauptthemen laut MEDLINE: Toxoplasma, Toxoplasmosis, Ocular. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JSPS KAKENHI, Ministry of Health, Labor, and Welfare of Japan, Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
Toxoplasma gondii, an obligate intracellular parasite, is a globally prevalent pathogen capable of infecting a wide range of warm-blooded animals, including humans. Ocular toxoplasmosis (OT), a severe manifestation of T. gondii infection, can lead to potentially blinding complications. This comprehensive review delves into the current understanding of T. gondii biology, exploring its complex life cycle, diverse transmission routes, and strain diversity. This article provides an in-depth analysis of the clinical manifestations of OT, which can result from both congenital and acquired infections, presenting a spectrum of signs and symptoms. The review examines various diagnostic strategies employed for OT, including clinical examination, multimodal imaging techniques such as fundus fluorescein angiography (FFA), indocyanine green angiography (ICGA), optical coherence tomography (OCT), and optical coherence tomography angiography (OCTA), as well as laboratory tests including serology and molecular methods. Despite extensive research, the specific mechanisms underlying ocular involvement in T. gondii infection remain elusive, and current diagnostic options have limitations. Moreover, the treatment of active and recurrent OT remains a challenge. While existing therapies, such as antimicrobial agents and immunosuppressants, can control active infections, they do not offer a definitive cure or completely prevent recurrence. The clinical endpoints for the management of active and recurrent OT are also not yet well-established, and the available treatment methods carry the potential for adverse effects. This article highlights the need for future research to elucidate the pathogenesis of OT, investigate genetic factors influencing susceptibility to infection, and develop more sensitive and specific diagnostic tools. Enhancing global surveillance, implementing robust prevention strategies, and fostering multidisciplinary collaborations will be crucial in reducing the burden of OT and improving patient outcomes. This comprehensive review aims to provide a valuable resource for clinicians, researchers, and policymakers, contributing to a better understanding of T. gondii infection and its impact on ocular health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology & Visual Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo 113-8510, Japan.
ORCID-Profile: Jing Zhang, Yaru Zou
Förderung
- JSPS KAKENHI
- Ministry of Health, Labor, and Welfare of Japan
- Japan Agency for Medical Research and Development
- Takeda Science Foundation
Zitieren
APA
Miyagaki, M., Zong, Y., Yang, M., Zhang, J., Zou, Y., Ohno-Matsui, K., & Kamoi, K. (2024). Ocular Toxoplasmosis: Advances in Toxoplasma gondii Biology, Clinical Manifestations, Diagnostics, and Therapy. Pathogens, 13(10), 898. https://doi.org/10.3390/pathogens13100898
Vancouver
Miyagaki M, Zong Y, Yang M, Zhang J, Zou Y, Ohno-Matsui K, et al. Ocular Toxoplasmosis: Advances in Toxoplasma gondii Biology, Clinical Manifestations, Diagnostics, and Therapy. Pathogens. 2024;13(10):898. doi:10.3390/pathogens13100898
BibTeX
@article{Miyagaki2024,
author = {Miyagaki, Miki and Zong, Yuan and Yang, Mingming and Zhang, Jing and Zou, Yaru and Ohno-Matsui, Kyoko and Kamoi, Koju},
title = {Ocular Toxoplasmosis: Advances in Toxoplasma gondii Biology, Clinical Manifestations, Diagnostics, and Therapy},
journal = {Pathogens},
year = {2024},
volume = {13},
number = {10},
pages = {898},
doi = {10.3390/pathogens13100898}
}
EUVIMED